Beauty Health (NASDAQ:SKIN – Get Free Report) and Niagen Bioscience (NASDAQ:NAGE – Get Free Report) are both small-cap consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, institutional ownership, risk and profitability.
Analyst Ratings
This is a breakdown of current ratings for Beauty Health and Niagen Bioscience, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Beauty Health | 1 | 5 | 1 | 0 | 2.00 |
| Niagen Bioscience | 0 | 1 | 3 | 1 | 3.00 |
Beauty Health currently has a consensus price target of $1.38, suggesting a potential upside of 118.25%. Niagen Bioscience has a consensus price target of $10.33, suggesting a potential upside of 253.88%. Given Niagen Bioscience’s stronger consensus rating and higher possible upside, analysts clearly believe Niagen Bioscience is more favorable than Beauty Health.
Institutional & Insider Ownership
Earnings and Valuation
This table compares Beauty Health and Niagen Bioscience”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Beauty Health | $300.80 million | 0.27 | -$9.52 million | ($0.22) | -2.86 |
| Niagen Bioscience | $129.42 million | 1.80 | $17.38 million | $0.18 | 16.22 |
Niagen Bioscience has lower revenue, but higher earnings than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than Niagen Bioscience, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Beauty Health has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, Niagen Bioscience has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500.
Profitability
This table compares Beauty Health and Niagen Bioscience’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Beauty Health | -9.79% | -47.83% | -5.79% |
| Niagen Bioscience | 12.39% | 17.95% | 13.17% |
Summary
Niagen Bioscience beats Beauty Health on 12 of the 15 factors compared between the two stocks.
About Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
About Niagen Bioscience
Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.
